Department of Nephrology, Hitachi General Hospital, 2-1-1 Johnan-chou, Hitachi, Ibaraki, 317-0077, Japan.
Department of Nephrology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
J Artif Organs. 2021 Jun;24(2):296-300. doi: 10.1007/s10047-020-01215-7. Epub 2020 Oct 3.
Several reports have demonstrated that peritoneal rest (PR) is considered to preserve the peritoneal function in peritoneal dialysis (PD) patients. However, there has been no report that examines the peritoneal permeability before and after a short-term PR of two days. We examined the effect of the two-day PR on peritoneal permeability. We observed and compared the daily PD ultrafiltration changes in the four PD and hemodialysis (HD) combination patients from the start of dialysis therapy throughout the total observation period of each case. Next, 6 months after the initiation of dialysis therapy we performed a set of peritoneal equilibrium tests (PET) before and after the 2-day PR. D/P creatinine, daily urine volume, daily ultrafiltration volume in PD, weekly residual renal creatinine clearance, and weekly PD creatinine clearance were measured. The daily PD ultrafiltration volume increased significantly after the 2-day PR, and gradually decreased over the last four days throughout the observation period in each patient. In the PET results, D/P creatinine in all patients decreased after the short-term PR, and accordingly the peritoneal ultrafiltration volume increased. However, urine volume, residual renal creatinine clearance, and peritoneal creatinine clearance did not change. The peritoneal permeability clearly decreased after the short-term PR. The repeated improvement in the PD ultrafiltration volume after the short-term PR implies that the peritoneal permeability alteration might be due to a reversible functional change in the initial dialysis period. These results suggest that a short-term PR may preserve the peritoneal function.
已有数项报告表明,腹腔休息(PR)被认为可维持腹膜透析(PD)患者的腹膜功能。然而,目前尚无报告检查短期 PR(持续两天)前后的腹膜通透性。我们检查了两天 PR 对腹膜通透性的影响。我们观察并比较了从透析治疗开始到每个病例的总观察期内,四位 PD 和血液透析(HD)联合患者的每日 PD 超滤变化。接下来,在透析治疗开始后的 6 个月,我们在 PR 前后进行了一组腹膜平衡试验(PET)。测量了 D/P 肌酐、每日尿量、PD 每日超滤量、每周残余肾肌酐清除率和每周 PD 肌酐清除率。在 PR 后,每日 PD 超滤量明显增加,在每个患者的观察期内,最后四天逐渐减少。在 PET 结果中,所有患者的 D/P 肌酐在短期 PR 后均下降,因此腹膜超滤量增加。然而,尿量、残余肾肌酐清除率和腹膜肌酐清除率没有变化。短期 PR 后腹膜通透性明显下降。短期 PR 后 PD 超滤量的反复改善表明,腹膜通透性的改变可能是由于初始透析期的可逆功能变化所致。这些结果表明,短期 PR 可能有助于维持腹膜功能。